Literature DB >> 1984092

Surgical management and prognosis of renal cell carcinoma invading the vena cava.

P A Hatcher1, E E Anderson, D F Paulson, C C Carson, J E Robertson.   

Abstract

A total of 44 patients with renal cell carcinoma and vena caval tumor thrombus underwent surgical resection. Of these patients 27 had primary tumor confined within Gerota's fascia, negative lymph nodes and no distant metastases (stage T3cN0M0). Patients who underwent extraction of a mobile tumor thrombus from the vena cava had a 69% 5-year survival rate (median 9.9 years) but patients with tumor thrombus directly invading the vena cava had a 26% 5-year survival rate (median 1.2 years), which improved to 57% (median 5.3 years) if the involved vena caval side wall was resected successfully. Of these patients 17 had renal cell carcinoma with vena caval thrombus as well as extrafascial extension, regional lymphadenopathy or distant metastases, and the 5-year survival rate was less than 18% in all groups (median survival less than 0.9 years). Prognosis was determined by the pathological stage of the renal cell carcinoma and by the presence or absence of vena caval side wall invasion but not by the level of tumor thrombus extension. Patients with incomplete resection of localized renal cell carcinoma with tumor thrombus do not survive any longer than those with extensive cancer, positive lymph nodes or distant metastases. However, when partial venacavectomy establishes negative surgical margins then survival markedly improves.

Entities:  

Mesh:

Year:  1991        PMID: 1984092     DOI: 10.1016/s0022-5347(17)38235-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  34 in total

1.  Successful removal of uterine leiomyosarcoma tumour thrombus propagating to the right atrium.

Authors:  Yu Hui Lim; Lui Shiong Lee; Chong Hee Lim; Ghee Kheng Chew
Journal:  BMJ Case Rep       Date:  2015-11-25

Review 2.  Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).

Authors:  Juan I Martínez-Salamanca; Estefania Linares; Javier González; Roberto Bertini; Joaquín A Carballido; Thomas Chromecki; Gaetano Ciancio; Sia Daneshmand; Christopher P Evans; Paolo Gontero; Axel Haferkamp; Markus Hohenfellner; William C Huang; Theresa M Koppie; Viraj A Master; Rayan Matloob; James M McKiernan; Carrie M Mlynarczyk; Francesco Montorsi; Hao G Nguyen; Giacomo Novara; Sascha Pahernik; Juan Palou; Raj S Pruthi; Krishna Ramaswamy; Oscar Rodriguez Faba; Paul Russo; Shahrokh F Shariat; Martin Spahn; Carlo Terrone; Derya Tilki; Daniel Vergho; Eric M Wallen; Evanguelos Xylinas; Richard Zigeuner; John A Libertino
Journal:  Curr Urol Rep       Date:  2014-05       Impact factor: 3.092

3.  Locally advanced renal cell carcinoma.

Authors:  Mohammed Al Otaibi; Simon Tanguay
Journal:  Can Urol Assoc J       Date:  2007-06       Impact factor: 1.862

4.  [Evaluating inferior vena cava wall invasion in renal cell carcinoma tumor thrombus with MRI].

Authors:  J Y Wu; Y Mi; S Liu; L Yao; Q Tang; Z S He; X Y Wang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

Review 5.  Caval thrombus in conjunction with renal tumors: indication for surgery and technical details.

Authors:  J González; G Ciancio
Journal:  Curr Urol Rep       Date:  2014-11       Impact factor: 3.092

6.  Significance of angiogenesis and microvascular invasion in renal cell carcinoma.

Authors:  Yoram Dekel; Rumelia Koren; Valentina Kugel; Pinhas M Livne; Rivka Gal
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

7.  Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival.

Authors:  Rene Mager; Siamak Daneshmand; Christopher P Evans; Joan Palou; Juan I Martínez-Salamanca; Viraj A Master; James M McKiernan; John A Libertino; Axel Haferkamp; Axel Haferkamp; Umberto Capitanio; Joaquín A Carballido; Venancio Chantada; Thomas Chromecki; Gaetano Ciancio; Siamak Daneshmand; Christopher P Evans; Paolo Gontero; Javier González; Markus Hohenfellner; William C Huang; Theresa M Koppie; John A Libertino; Estefanía Linares Espinós; Adam Lorentz; Juan I Martínez-Salamanca; Viraj A Master; James M McKiernan; Francesco Montorsi; Giacomo Novara; Padraic O'Malley; Sascha Pahernik; Joan Palou; José Luis Pontones Moreno; Raj S Pruthi; Oscar Rodriguez Faba; Paul Russo; Douglas S Scherr; Shahrokh F Shariat; Martin Spahn; Carlo Terrone; Derya Tilki; Dario Vázquez-Martul; Cesar Vera Donoso; Daniel Vergho; Eric M Wallen; Richard Zigeuner
Journal:  J Surg Oncol       Date:  2016-08-26       Impact factor: 3.454

8.  Surgical resection of a renal cell carcinoma involving the inferior vena cava: the role of the cardiothoracic surgeon.

Authors:  Haralabos Parissis; Mohammad Taukeer Akbar; Michael Tolan; Vincent Young
Journal:  J Cardiothorac Surg       Date:  2010-11-05       Impact factor: 1.637

9.  Surgical treatment of inferior vena cava tumor thrombus in patients with renal cell carcinoma.

Authors:  Tae-Won Kwon; Hyangkyoung Kim; Ki-Myung Moon; Yong-Pil Cho; Cheryn Song; Chung-Soo Kim; Hanjong Ahn
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153

10.  Staging of renal cell carcinoma: Current concepts.

Authors:  John S Lam; Tobias Klatte; Alberto Breda
Journal:  Indian J Urol       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.